Le Lézard
Classified in: Health
Subjects: MAV, FVT, CFG, MAT

Notice to the Media - Government of Canada to comment on the passage of Bill C-45


OTTAWA, June 19, 2018 /CNW/ - The Honourable Ginette Petitpas Taylor, Minister of Health, the Honourable Jody Wilson-Raybould, Minister of Justice and Attorney General of Canada, along with Parliamentary Secretary Bill Blair, will be available to media to comment on the passage of Bill C-45 in the Senate.

Date
June 20, 2018

Time
9:30 a.m. (EDT)

Location
Foyer
House of Commons, Parliament Hill
Ottawa, ON

 

SOURCE Health Canada


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: